Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Meg Franklin"'
Autor:
Meg Franklin
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 27:1618-1620
DISCLOSURES: No funding was received for the writing of this commentary. The author has nothing to disclose.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b40fa3c67acfc17514c2ff43ea4ac91d
https://doi.org/10.18553/jmcp.2021.27.11.1618
https://doi.org/10.18553/jmcp.2021.27.11.1618
Publikováno v:
Journal of Comparative Effectiveness Research. 10:169-173
Composite renal end points and end stage renal disease (ESRD) are frequently included as prespecified secondary end points in the cardiovascular outcomes trials (CVOTs) of diabetes medications. We examined the heterogeneity in the definitions of comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b697e082a08e59bdc892359e0cf122b3
https://doi.org/10.2217/cer-2020-0137
https://doi.org/10.2217/cer-2020-0137
Publikováno v:
Blood. 140:12554-12555
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17b9b4066779010bc875ce02aa557e25
https://doi.org/10.1182/blood-2022-167184
https://doi.org/10.1182/blood-2022-167184
Autor:
Eric Druyts, Meg Franklin
Publikováno v:
Journal of managed carespecialty pharmacy. 26(11)
DISCLOSURES: No funding supported the writing of this commentary. The authors have nothing to disclose.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4923d55514bc8fc9e7f5a32fd237f86
https://pubmed.ncbi.nlm.nih.gov/33119438
https://pubmed.ncbi.nlm.nih.gov/33119438
Patients undergoing general surgical procedures are at increased risk for venous thromboembolism (VTE). Compliance rates with established guidelines for VTE thromboprophylaxis in patients at moderate-to-high risk are notably low. Recent literature ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8984d849af5744d1de7ed19eb6ca7429
Objective: Evaluate the incidence of type 2 diabetes mellitus (T2DM) and hyperlipidemia (HLD) in CML patients initiating therapy with dasatinib or nilotinib. Methods: Retrospective study using MarketScan claims from January 2006 to December 2014. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d8682c44d49e6f8bb45e4081df14891
Publikováno v:
Journal of Managed Care Pharmacy. 20:795-799
BACKGROUND: Fingolimod, an oral immunomodulatory therapy approved to treat multiple sclerosis (MS) is contraindicated in patients with certain cardiac conditions, yet the frequency of these conditions in patients with MS is not known. This study asse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06be79064517d8a138cc6a3d1ad07f4d
https://doi.org/10.18553/jmcp.2014.20.8.795
https://doi.org/10.18553/jmcp.2014.20.8.795
Autor:
Meg Franklin, Nancy H. Goodbar, Phillip Buckhaults, Kathryn N. Freeland, Eddie Grace, Katherine G. Moore, Christopher L. Farrell
Publikováno v:
Currents in Pharmacy Teaching and Learning. 6:571-576
This article describes how to introduce pharmacy students to online pharmacogenomic resources and also to apply pharmacogenomics to clinical patient scenarios. This novel approach has been successful by integrating medical genomics into a core curric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2095079866528e54315fc2a1dba35d32
https://doi.org/10.1016/j.cptl.2014.04.015
https://doi.org/10.1016/j.cptl.2014.04.015
Autor:
Orsolya Lunacsek, Meg Franklin, Sunil V. Rao, Laura E. Happe, Ruslan Horblyuk, Laura Menditto
Publikováno v:
Current Medical Research and Opinion. 25:413-420
To evaluate the burden of major bleed in patients with non-ST segment elevation acute coronary syndromes (NSTE ACS) receiving injectable anticoagulation from the hospital perspective.Retrospective analysis of inpatient medical and pharmacy data from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f5678584aa653e5427286bf0520e63f
https://doi.org/10.1185/03007990802649133
https://doi.org/10.1185/03007990802649133
Autor:
Meg Franklin, Edith A. Nutescu, Laura E. Happe, Eileen Farrelly, Andrew F. Shorr, Ruslan Horblyuk
Publikováno v:
Annals of Pharmacotherapy. 42:1222-1228
Background Multiple clinical studies have shown postdischarge anticoagulation to bo beneficial following major orthopedic surgery (MOS); however, outpatient prophylaxis is not widely practiced. Objective To quantify, from a third-party payer perspect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e47d042c4c17b978672fea59509ec565
https://doi.org/10.1345/aph.1l113
https://doi.org/10.1345/aph.1l113